An interview with Dr. Sharon Giordano, co-chair on “Abemaciclib with Endocrine Therapy in the Treatment of High-Risk Early Breast Cancer: ASCO Optimal Adjuvant Chemotherapy and Targeted Therapy Guideline Rapid Recommendation Update.” Dr. Giordano discusses the results and impact of the monarchE trial, the updated recommendations on the use of abemaciclib, and impact for clinicians and patients. For more information, visit www.asco.org/breast-cancer-guidelines.
View all episodes
By American Society of Clinical Oncology (ASCO)
4.6
4343 ratings
An interview with Dr. Sharon Giordano, co-chair on “Abemaciclib with Endocrine Therapy in the Treatment of High-Risk Early Breast Cancer: ASCO Optimal Adjuvant Chemotherapy and Targeted Therapy Guideline Rapid Recommendation Update.” Dr. Giordano discusses the results and impact of the monarchE trial, the updated recommendations on the use of abemaciclib, and impact for clinicians and patients. For more information, visit www.asco.org/breast-cancer-guidelines.
140 Listeners
17 Listeners
324 Listeners
41 Listeners
111 Listeners
506 Listeners
60 Listeners
282 Listeners
3,336 Listeners
182 Listeners
23 Listeners
26,508 Listeners
181 Listeners
3 Listeners
40 Listeners